Patent 10246466 was granted and assigned to TP Therapeutics on April, 2019 by the United States Patent and Trademark Office.
The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation.